From DSM’s perspective, the acquisition of biomaterial components manufacturer Kensey Nash of Exton in 2012 was an important step in realizing the Netherland-based company’s ambition to build strong positions in bio-passive, bio-active and bio-interactive materials.

Kensey Nash, a pioneer in developing, manufacturing and selling medical device parts used in cardiology, orthopaedic, sports medicine, spinal and general surgery, is considered a leader in technology-driven biomedicine.

As explained in the video below, as life expectancy continues to increase and people want to remain physically active, growth in the biomedical materials market will remain high.

Biomedical is one of the key areas where DSM is able to fully leverage its unique science-based expertise in life and materials sciences.